Photo by 77hn from unsplash
Follicular lymphoma is the most common indolent lymphoma in the United States. In this review article, the authors discuss the different prognostic biomarkers available for follicular lymphoma. Treatment options, including… Click to show full abstract
Follicular lymphoma is the most common indolent lymphoma in the United States. In this review article, the authors discuss the different prognostic biomarkers available for follicular lymphoma. Treatment options, including observation, immunotherapy versus chemoimmunotherapy, in both the frontline and the relapse setting are also discussed in detail. Patients with follicular lymphoma with unmet needs include those with early relapse, with multiple relapses, and with histologic transformation. The treatment options for these patients are not well defined, and the authors discuss the available data for treating these patients.
Journal Title: Hematology/oncology clinics of North America
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!